Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferrous (II) Glycine Sulphate Complex vs Polyferose in Iron Deficiency Anemia
NCT01425463Phase 3Completed
- Sponsor
- Sanol GmbH
- Start
- Mar 2011
- Primary completion
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ferroglycine sulfate in iron deficiency anemia (IDA) (2 arms), sponsored by Sanol GmbH. Primary endpoint: Change in Hemoglobin (Hb) From Baseline at 12 weeks. Started Mar 2011; status: completed.
02
Drugs
ferroglycine sulfate
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT01425463.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01425463.